Investing Profile

Alaa Halawa(1)

InvestorVC
Investing in and building transformative companies at the intersection of technology and healthcare
mubadala.comLos Altos, California

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Mubadala Investor
$10K - $5.0M
$100K
15
CompanyStageDateRound SizeTotal Raised
Tenvie Therapeutics
Series AJan 2025$200M
$200M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Paul Berns (ARCH Venture Partners), Kristina Burow (ARCH Venture Partners)
GC Therapeutics
Series ASep 2024$65M
$65M
Rejuveron Life Sciences
Series BSep 2023$75M
$75M
EpiBiologics
Series AMar 2023$73M
$96M
Co-investors: David Schenkein (GV (Google Ventures)), Alexandra Cantley (Polaris Partners), Samuel Bjork (Digitalis Ventures)
Paradigm
Series AJan 2023$200M
$240M
Co-investors: Elena Viboch (General Catalyst), Hemant Taneja (General Catalyst), Ramnik Arora (FTX Ventures), Bilal Zuberi (Lux Capital), Stephen Knight (F-Prime Capital Partners), Brett Cook (F-Prime Capital Partners), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Jared Friedman (Y Combinator), Scott Belsky, Arash Ferdowsi, Eoghan McCabe
UpStream Care
Series BDec 2022$140M
$140M
Co-investors: Eric Jones (Dragoneer Investment Group), Lynne Chou O’Keefe (Define Ventures), Chirag Shah (Define Ventures), Ayman AlAbdallah
Neumora Therapeutics
Series BOct 2022$110M
$510M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Kristina Burow (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners)
Alloy Therapeutics
Series DOct 2022$42M
Series CApr 2021$75M
$130M
Co-investors: Alex Kolicich (8VC), Peter Thiel (Founders Fund), Fabian Hansen (Presight Capital)